New RealWorld Data Analyses Support the LongTerm Use of Entyvio in BioNave...
Deerfield IL October 8 2018Ć Takeda Pharmaceuticals U.S.A. Inc. Takeda today announced the presentation of new longterm efficacy realworld data analyses for EntyvioĆĆvedolizumab at ACG 2018 in...
View ArticleGrowthDifferentiation Factor 8 Myostatin or GDF8 or MSTN Pipeline Review H2...
GrowthDifferentiation Factor 8 Myostatin or GDF8 or MSTN Pipeline Review H2 2018SummaryGrowthDifferentiation Factor 8 Myostatin or GDF8 or MSTN Myostatin also known as growth differentiation factor 8...
View ArticleGlobal Crohn s Disease Drug Market Status and Outlook 20182025 Report Updated...
Report SnapshotKey Content of Chapters Including and can be customized report is a semifinished version and it takes 4872 hours to upgradePart 1Terminology Definition Industry ChainIndustry Dynamics...
View ArticleJanssen's Stelara shows promise across two dosages in ulcerative colitis
Janssens biologic therapy Stelara ustekinumab has shown new efficacy in the treatment of moderate to severe ulcerative colitis in two dosage groups with both reporting statistically significant...
View ArticleuBiome Launches Innovation Challenge to Advance Microbiome Clinical Outcomes...
The leader in microbial genomics announces partnership with Medstro in a call for microbiome research studies focused on clinical outcomes.SAN FRANCISCO PRWEB October 09 2018 Submissions to the uBiome...
View ArticleNew Phase 3 Data Show Single Dose of STELARAĆ Ustekinumab Induces Clinical...
8week induction data from pivotal Phase 3 UNIFI study presented during plenary session at the American College of Gastroenterology ACG Annual Scientific Meeting 2018 The Janssen Pharmaceutical...
View ArticleInvest in Cures Forum November 1 Offers Insights Connections into Impact...
Representatives from 8 Nonprofit Disease Foundations to Discuss Investment Strategy at NC Biotechnology CenterDURHAM N.C. PRWEB October 09 2018 LaunchBio Inc. a nonprofit organization that identifies...
View ArticleJ&J blockbuster find latestage trial success in chronic bowel disease study
Stelara was previously approved for psoriasis psoriatic arthritis and Crohn's disease
View ArticleNon Receptor Tyrosine Protein Kinase TYK2 TYK2 or EC 2.7.10.2 Pipeline Review...
Non Receptor Tyrosine Protein Kinase TYK2 TYK2 or EC 2.7.10.2 Pipeline Review H2 2018SummaryNon Receptor Tyrosine Protein Kinase TYK2 TYK2 or EC 2.7.10.2 pipeline Target constitutes close to 18...
View ArticleNIH Awards $1M Clinical Research Grant to NUNM OSU & Pacific NW National Lab
The fouryear R01 research project investigates the potential of a dietderived therapeutic to target inflammatory bowel disease and the microbial imbalance contributing to the inflammation.PORTLAND Ore....
View ArticleMedical News Today Best medications for treating diarrhea in Crohn's disease
Diarrhea is common in Crohns disease and can come on suddenly greatly interfering with a persons daily life. Here we look at the different antidiarrheal medications that may help people with Crohns who...
View ArticleNew Analyses from Pivotal Phase 3 Trials of Oral Ozanimod to Be Presented at...
Ozanimod showed effects on cognitive processing speed in a post hoc analysis of 12month data from SUNBEAM pivotal trial In separate post hoc analysis of pooled data from phase 3 RADIANCE Part B and...
View ArticleRealworld Efficacy of Vedolizumab for the Treatment of IBD
This study evaluated clinical and objective response and remission rates with vedolizumab for treatment of Crohn's disease and ulcerative colitis in a large real world cohort. Alimentary Pharmacology...
View ArticleNew data sets up potential new gastro use for J&J's Stelara
Janssens Stelara has shown positive results in an ulcerative colitis UC trial setting up a potential new indication for the inflammatory diseases drug.Stelara is already approved in psoriasis...
View ArticleuBiome the Leader in Microbial Genomics Launches Research Collaboration with...
SmartGut patients can now join a research study to learn about weight loss and the microbiome.SAN FRANCISCO PRWEB October 10 2018 uBiome the leader in microbial genomics has launched a research study...
View ArticleThis Biotech Is 'Harnessing the Microbiome's Therapeutic Potential'
Source Streetwise Reports 10102018 A LifeSci Capital report presented a handful of key points about the firm.In a Oct. 5 research note analyst Patrick Dolezal reported that LifeSci Capital initiated...
View ArticleGlobal Crohn's Disease Market and Competitive Landscape 2018...
ResearchAndMarkets.comLaura Wood Senior Managerpressresearchandmarkets.comFor E.S.T Office Hours Call 19173000470For U.S.CAN Toll Free Call 18005268630For GMT Office Hours Call 35314168900Related...
View ArticleAevi Genomic Medicine Inc GNMX Medical Equipment Deals and Alliances Profile...
SummaryAevi Genomic Medicine Inc Aevi formerly Medgenics Inc is a research and development company that discovers and develops novel therapies for pediatric onset and lifealtering diseases.The company...
View ArticleArena Pharmaceuticals Inc ARNA Pharmaceuticals Healthcare Deals and Alliances...
SummaryArena Pharmaceuticals Inc Arena is a biopharmaceutical company which discovers develops and commercializes small molecule drugs in multiple therapy areas. It is evaluating its lead candidate...
View Article